SciELO - Scientific Electronic Library Online

 
vol.5 issue1Joint hypermobility determined by the Beighton score in university studentsGiant cell arteritis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Paraguaya de Reumatología

On-line version ISSN 2413-4341

Abstract

ZERON, Samara Mendieta  and  MARIN, Katherine Henao. Determination of growth status, levels of insulin growth factor type 1 (IGF-1) and vitamin D in patients with juvenile idiopathic arthritis treated at the IssemYm maternal and Child Hospital in Toluca de Lerdo, Mexico. Rev. parag. reumatol. [online]. 2019, vol.5, n.1, pp.13-19. ISSN 2413-4341.  https://doi.org/10.18004/rpr/2019.05.01.13-19.

Introduction: Growth delay has been described in children with juvenile idiopathic arthritis (JIA). Low vitamin D and insulin growth factor type 1 ( IGF-1) have been reported in this disease and seem to be related to the inadequete bone development and subsequent growht delay. Objetive: To determine growth status, levels of IGF-1, and Vitamin D in patients with JIA, acording to JIA subtype, received treatment, disease duration, age and gender of each patient. methods: Thirteen (13) children with JIA were included in this cohort sutdy . Patients were seen on an ambulatory basis from february through may of 2019. They recevied a clinical and anthropometric evaluation and serum was collected for Vitamin D[25(OH)D], IGF-1 and PTH measurement through chemiluminescent immunoessays. Growth charts approved by the CDC were also used to determine the patients’ growth status. Results and discussion: Vitamin D insuficiency was observed in 84,62% of patients, including those wiht growth delay (15,38%). Accordin to different authors, this could be a cause of such delay, but we are unable to draw conclusions with this study. Insulin growth factor 1 (IGF-1) was normal in all patients. Use of corticosteroids, disease duration, JIA subtype or treatment, age and gender were not found to be implicated as risk factors for growth delay. Conclusion: Growth delay was found in 15,38% of the patientes. Significant Vitamin D insuficiency was identified in patients with JIA, which suggest that further studies might identify variables that might correlated with this deficit.

Keywords : Juvenile idiopathic arthritis (JIA); insulin growth factor type 1 (IGF-1); vitamin D; parathyroid hormone (PTH); growth.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )